SCHEMBL10149336

SCHEMBL10149336

CC(=O)Oc1cc(C)cc(/C=C/c2cc(OC(C)=O)c(OC(C)=O)c(OC(C)=O)c2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.54
KDM4E B2RXH2 1/20 0.54
MEN1 O00255 1/20 0.54
TTR P02766 1/20 0.54
TP53 P04637 1/20 0.54
CYP3A4 P08684 1/20 0.54
MAPT P10636 1/20 0.54
KMT2A Q03164 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
TUBB4A P04350 2/20 0.54
TUBB P07437 2/20 0.54
TUBA3C P0DPH7 2/20 0.54
TUBA1B P68363 2/20 0.54
TUBA4A P68366 2/20 0.54
TUBB4B P68371 2/20 0.54
TUBB3 Q13509 2/20 0.54
TUBB2A Q13885 2/20 0.54
TUBB8 Q3ZCM7 2/20 0.54
TUBA3E Q6PEY2 2/20 0.54
TUBA1A Q71U36 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10149330 0.91 TUBB4A (0.55) LMNAKDM4EMEN1TTRTP53
SCHEMBL715257 0.91 KDM4E (0.65) LMNAKDM4EMEN1TTRTP53
SCHEMBL10149312 0.87 LMNA (0.69) LMNAKDM4EMEN1TTRTP53
SCHEMBL10149318 0.84 LMNA (0.69) LMNAKDM4EMEN1TTRTP53
SCHEMBL13259325 0.81 LMNA (0.71) LMNAKDM4EMEN1TTRTP53
SCHEMBL16192390 0.81 TUBB4A (0.68) LMNAKDM4EMEN1TTRTP53
SCHEMBL13259327 0.81 LMNA (0.81) LMNAKDM4EMEN1TTRTP53
SCHEMBL16192389 0.81 TUBB4A (0.68) LMNAKDM4EMEN1TTRTP53
SCHEMBL10149023 0.81 TUBB4A (0.64) LMNAKDM4EMEN1TTRTP53
SCHEMBL717041 0.81 TUBB4A (0.73) LMNAKDM4EMEN1TTRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160288090-A1 MOLECULARLY IMPRINTED POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2016-10-06 US disclosed
US-20120052757-A1 MOLECULARLY IMPRINTED POLYMERS MONASH UNIVERSITY (AU) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160288090-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 LMNA 3479/4885KDM4E 738/4885MEN1 698/4885
US-20120052757-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 LMNA 3479/4885KDM4E 738/4885MEN1 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.